Taking guard on Zika

Every year, several lives across the world are lost or debilitated due to vector-borne diseases such as dengue and chikungunya. In India, the first case of dengue was detected in 1964 in Kolkata, with numbers rising due to a lack of vector control, unplanned urbanisation, climate change and varying immunological reasons. The same holds true for chikungunya, another debilitating mosquito-transmitted disease. After remaining incipient for almost 32 years, chikungunya re-emerged, in 2006, with more than 1.5 million cases reported in India, and causing deaths or long-lasting physical impairment in millions of individuals around the globe. While India struggled with the double burden of dengue and chikungunya, a covert virus called Zika sprang into action. India had gathered its first evidence of Zika in 1954, through a preliminary study conducted by the Indian Council of Medical Research’s (ICMR) National Institute of Virology (NIV) in Pune. Limited knowledge suggested that the Zika virus caused a milder form of dengue viral illness: low grade fever, headache and malaise in 20% of infected individuals, whereas 80% of those infected remain asymptomatic. The African strain caused major outbreaks in the Yap islands and French Polynesia in 2007 and 2013, respectively. Zika became relentless with reports of a sudden, unexplained spike in the number of babies born with microcephaly (small heads) and brain damage in Brazil and other parts of Latin America, baffling public health professionals. Prior to this outbreak, there was very limited research on Zika. Today, there are more than 5,000 published research articles. The disease spectrum of Zika ranges from asymptomatic or mild illness to severe birth defects, and Guillain-Barre Syndrome, a post-viral neurological syndrome causing partial or complete paralysis in adults. Unlike dengue, Zika can pass through the placenta and infect the foetus, causing neurological damage. Unlike dengue, Zika is also transmitted through the sexual route. There is also a risk, after blood transfusion from an infected individual. The complexity of tackling Zika is augmented by the absence of a vaccine or drug to prevent/treat the infection. Zika was declared a public health emergency by the World Health Organisation (WHO) in 2016. The Ministry of Health and Family Welfare designated the ICMR with the task of setting up human and mosquito surveillance for Zika Virus Disease (ZVD) in India. The first case was confirmed in Ahmedabad, Gujarat, in November 2016. Subsequently, three more cases: two from Gujarat and one from Tamil Nadu were reported through ICMR surveillance. The Gujarat strain was found to resemble the Zika strains from Malaysia in 1966, which seemed to have relatively low outbreak potential and led to the belief that it may not cause great damage. Need for multiple engagement However, this was far from the reality. The ICMR’s surveillance detected the onset of a major outbreak of ZVD in Jaipur city in September 2018. Its control became a challenging task. Many pregnant women also tested positive. However, it is critical to understand that the positive number of ZVD cases may be the tip of the iceberg, given its asymptomatic nature. It is possible that high population mobility resulted in a spread of ZVD to parts of Gujarat and Madhya Pradesh. While Jaipur has not reported new cases since October 29, 2018, reports of sporadic cases have been trickling in from Gujarat. There is also active ZVD transmission ongoing in Bhopal and its neighbouring districts. Genetic sequencing of the Jaipur Zika strain has revealed a close resemblance to the deadly outbreak strain in Brazil. but a sequencing of the Rajasthan Zika strains has shown that the known mutation for microcephaly is not present in them. But high vigil is a must as the absence of these mutations does not rule out the possibility of microcephaly. This wakeup call highlights the need for multi-sectoral engagement to achieve effective vector control, protecting us from ill-health, economic losses and a compromised future. Dr. Balram Bhargava is Director General, Indian Council of Medical Research (ICMR), New Delhi

Source  :  https://www.thehindu.com/todays-paper/tp-opinion/taking-guard-on-zika/article25645660.ece

About ChinmayaIAS Academy - Current Affairs

Check Also


According to the International Renewable Energy Agency (IRENA), hydrogen will make up 12% of the …

Leave a Reply

Your email address will not be published.

Get Free Updates to Crack the Exam!
Subscribe to our Newsletter for free daily updates